TAS::75 0849::TAS DEVELOPMENT OF ANTI-CANCER AGENTS.

Information

• Research Project
• 8164614

• ApplicationId

  8164614

• Core Project Number

  261201000103C-0-0-1

• Full Project Number

  261201000103C-0-0-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  9/30/2010 - 14 years ago

• Project End Date

  6/30/2011 - 13 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2010

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• VM DISCOVERY INC.

The overall objective of this proposal is to preclinically develop VMD-1201 or a lead analog compound of a preferentially peripheral-acting PKC epsilon inhibitor as an oral targeted anticancer drug for treatment of human head and neck cancer with much reduced side effects. The long term goal of this developmental project is to develop this mechanism-based PKC epsilon specific inhibitor, through preclinical and human clinical trials, as an effective oral drug for advanced human head and neck cancer.

IC Name

• Activity

  N43

• Administering IC

  CA

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  198224

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  395

• Ed Inst. Type

• Funding ICs

  NCI:198224\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  VM DISCOVERY, INC.

• Organization Department

• Organization DUNS

  091227848

• Organization City

  FREMONT

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  945386461

• Organization District

  UNITED STATES